Construction of a Risk Prediction Model for Lung Cancer Based on Lifestyle Behaviors in the UK Biobank Large-Scale Population Cohort
Abstract
Keywords: Lung cancer, Risk prediction, Prediction model, Risk factor
Full Text:
PDFReferences
SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2021,71(3): 209–249. doi: 10. 3322/caac.21660.Epub2021Feb4.
VERNIERI C, NICHETTI F, RAIMONDI A, et al. Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol Hematol,2018,123: 57–73. doi: 10. 1016/j.critrevonc.2018.01.002.
BACH P B, KATTAN M W, THORNQUIST M D, et al. Variations in lung cancer risk amongsmokers. J Natl CancerInst,2003,95(6): 470–478. doi: 10.1093/jnci/95.6.470.
SPITZ M R, HONG W K, AMOS C I, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst,2007,99(9): 715–726. doi: 10.1093/jnci/djk153.
SPITZ M R, ETZEL C J, DONG Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila),2008,1(4): 250–254. doi: 10.1158/1940-6207.capr-08-0060.
El-ZEIN R A, LOPEZ M S, D′AMELIO A M, et al. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev,2014,23(11): 2462–2470. doi: 10.1158/1055-9965.EPI-14-0462.
CASSIDY A, MYLES J P, Van TONGEREN M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer, 2008,98(2): 270–276. doi: 10.1038/sj.bjc.6604158.
RAJI O Y, AGBAJE O F, DUFFY S W, et al. Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project. Cancer Prev Res (Phila),2010, 3(5): 664–669. doi: 10.1158/1940-6207.CAPR-09-0141.
MARCUS M W, CHEN Y, RAJI O Y, et al. Llpi: Liverpool lung project risk prediction model for lung cancer incidenc. Cancer Prev Res (Phila), 2015,8(6): 570–575. doi: 10.1158/1940-6207.capr-14-0438.
MARCUS M W, RAJI O Y, DUFFY S W, et al. Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model. Int J Oncol,2016,49(1): 361–370. doi: 10.3892/ijo.2016.3499.
ETZEL C J, KACHROO S, LIU M, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila),2008,1(4): 255–265. doi: 10.1158/1940-6207.capr-08-0082.
SPITZ M R, AMOS C I, LAND S, et al. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol,2013,8(4): 391–397. doi: 10.1097/JTO.0b013e318283da29.
TAMMEMAGI C M, PINSKY P F, CAPORASO N E, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst,2011,103(13): 1058–1068. doi: 10.1093/jnci/djr173.
TAMMEMAGI M C, LAM S C, MCWILLIAMS A M, et al. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila),2011,4(4): 552–561. doi: 10.1158/1940-6207.CAPR-10-0183.
TAMMEMAGI M C, KATKI H A, HOCKING W G, et al. Selection criteria for lung-cancer screening. N Engl J Med,2013,368(8): 728–736. doi: 10.1158/1940-6207.capr-10-0183.
HOGGART C, BRENNAN P, TJONNELAND A, et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila),2012,5(6): 834–846. doi: 10.1158/1940-6207.CAPR-11-0237.
CHARVAT H, SASAZUKI S, SHIMAZU T, et al. Development of a risk prediction model for lung cancer: the Japan public health center-based prospective study. Cancer Sci,2018,109(3): 854–862. doi: 10.1111/cas. 13509.
YOUNG R P, HOPKINS R J, HAY B A, et al. Lung cancer susceptibility model based on age, family history and genetic variants. PLoS One,2009, 4(4): e5302. doi: 10.1371/journal.pone.0005302.
Refbacks
- There are currently no refbacks.



